{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:38:43Z","timestamp":1759541923904,"version":"3.40.5"},"reference-count":309,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pneurobio.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T17:44:07Z","timestamp":1530726247000},"page":"135-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7324-1353","authenticated-orcid":false,"given":"Teodorico C.","family":"Ramalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre A.","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e1ssia S.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-6911","authenticated-orcid":false,"given":"Pedro H.","family":"Cesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine F.F.","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2018.06.011_bib0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/01616412.1997.11740784","article-title":"Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis","volume":"19","author":"Abe","year":"1997","journal-title":"Neurol. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0010","doi-asserted-by":"crossref","first-page":"L53","DOI":"10.1186\/2193-1801-4-S1-L53","article-title":"Sm-like proteins in the pathogenesis of spinal muscular atrophy","volume":"4","author":"Achsel","year":"2015","journal-title":"Springerplus"},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2018.06.011_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13506129.2012.673140","article-title":"Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy","volume":"19","author":"Ackermann","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1756285612470192","article-title":"Recent advances in the treatment of familial amyloid polyneuropathy","volume":"6","author":"Adams","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0025","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1586\/14737175.2014.983905","article-title":"Current and future treatment of amyloid neuropathies","volume":"14","author":"Adams","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-013-0435-3","article-title":"FAP neuropathy and emerging treatments","volume":"14","author":"Adams","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/14656566.2016.1145664","article-title":"TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies","volume":"17","author":"Adams","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm030347n","article-title":"Diflunisal analogues stabilize the native State of transthyretin. Potent inhibition of amyloidogenesis","volume":"47","author":"Adamski-Werner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.pneurobio.2018.06.011_bib0045","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.3233\/JAD-2010-100465","article-title":"Calcium and mitochondrial reactive oxygen species generation: how to read the facts","volume":"20","author":"Adam-Vizi","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0050","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/jne.12271","article-title":"The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption","volume":"27","author":"Alshehri","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0060","first-page":"8","article-title":"Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic Gene expression, and improves muscle function in dystrophic mdx mice","author":"Altamirano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/brain\/awf012","article-title":"Brain function in Duchenne muscular dystrophy","volume":"125","author":"Anderson","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0070","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.2174\/092986712800269317","article-title":"Diagnosis and therapeutic approaches to transthyretin amyloidosis","volume":"19","author":"Ando","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0080","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2174\/092986712800269281","article-title":"Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands","volume":"19","author":"Arsequell","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2014.09.008","article-title":"Familial amyloidosis: great progress for an orphan disease","volume":"62","author":"Barreiros","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-2236(93)90117-5","article-title":"Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?","volume":"16","author":"Beal","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0105","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0110","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1073\/pnas.1323842111","article-title":"Microtubule binding distinguishes dystrophin from utrophin","volume":"111","author":"Belanto","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0120","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1242\/jcs.03381","article-title":"Mitochondrial bioenergetics and structural network organization","volume":"120","author":"Benard","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/13506129.2012.668501","article-title":"Pathogenesis of transthyretin amyloidosis","volume":"19","author":"Benson","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/13506129.2012.678509","article-title":"The diflunisal trial: study accrual and drug tolerance","volume":"19","author":"Berk","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0140","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","article-title":"Protein oxidation in aging, disease, and oxidative stress","volume":"272","author":"Berlett","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0145","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.1764-10.2010","article-title":"In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular","volume":"30","author":"Biondi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0155","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2174\/0929867321666140916120118","article-title":"The glutamate hypothesis in ALS: pathophysiology and drug development","volume":"21","author":"Blasco","year":"2014","journal-title":"Curr. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0160","first-page":"729","article-title":"Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells","volume":"12","author":"Boda","year":"2004","journal-title":"Eur. J."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/187152710791292576","article-title":"Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target","volume":"9","author":"Bogaert","year":"2010","journal-title":"CNS Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0170","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0175","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0180","first-page":"225","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocrine"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.2003.047019","article-title":"Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle","volume":"553","author":"Bolster","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1079\/PNS2004355","article-title":"Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling","volume":"63","author":"Bolster","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnins.2014.00325","article-title":"GEMINs: potential therapeutic targets for spinal muscular atrophy?","volume":"8","author":"Borg","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0200","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-9-572","article-title":"A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies","volume":"9","author":"Bovolenta","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12031-007-0024-5","article-title":"Smn depletion alters profilin II expression and leads to upregulation of the RhoA\/ROCK pathway and defects in neuronal integrity","volume":"32","author":"Bowerman","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0210","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2337\/diabetes.48.9.1815","article-title":"Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans","volume":"48","author":"Bradley","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0215","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1523\/JNEUROSCI.2728-12.2013","article-title":"Shift from extracellular signal-regulated kinase to AKT\/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells","volume":"33","author":"Branchu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.trsl.2009.03.008","article-title":"Drug development for orphan diseases in the context of personalized medicine","volume":"154","author":"Brewer","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15216540152845993","article-title":"Nitric oxide, mitochondria, and cell death","volume":"52","author":"Brown","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0230","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.94.14.7606","article-title":"Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide di","volume":"94","author":"Bruijn","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0235","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1073\/pnas.0900122106","article-title":"Fibroblast growth factor\u20132 regulates the stability of nuclear bodies","volume":"106","author":"Bruns","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0240","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0250","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/geno.1996.0147","article-title":"Structure and organization of the human survival motor neurone (SMN) gene","volume":"32","author":"B\u00fcrglen","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/clpt.2010.193","article-title":"The impact of the orphan drug act on the development and advancement of neurological products for rare diseases: a descriptive review","volume":"88","author":"Burke","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nmd.2016.06.459","article-title":"Opening the window: the case for carrier and perinatal screening for spinal muscular atrophy","volume":"26","author":"Burns","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"LANCET Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jmb.2012.01.024","article-title":"A molecular history of the amyloidoses","volume":"421","author":"Buxbaum","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000315405","article-title":"The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications","volume":"8","author":"Callaghan","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/B:NERE.0000010442.89826.9c","article-title":"Taurine and skeletal muscle disorders","volume":"29","author":"Camerino","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0290","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.nmd.2014.06.104","article-title":"Effects of S48168\/Arm210, a new rycal (R) compound, on pathology related signs of exercised dystrophic mdx mouse","volume":"24","author":"Capogrosso","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10897-015-9859-z","article-title":"Review of Spinal Muscular Atrophy (SMA) for prenatal and pediatric genetic counselors","volume":"25","author":"Carr\u00e9","year":"2016","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0300","doi-asserted-by":"crossref","first-page":"16295","DOI":"10.1074\/jbc.M413111200","article-title":"Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis","volume":"280","author":"Casoni","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0310","first-page":"E598","article-title":"Fasting inhibits insul in-mediated glycolysis and anaplerosis in human skeletal-muscle","volume":"261","author":"Castillo","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0315","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.biocel.2006.02.010","article-title":"An overview of lipid peroxidation with emphasis in outer segments of photoreceptors and the chemiluminescence assay","volume":"38","author":"Catal\u00e1","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0320","first-page":"911","article-title":"Dexpramipexole, the R (+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis","volume":"13","author":"Cheah","year":"2010","journal-title":"IDrugs Investig. Drugs J."},{"issue":"Suppl","key":"10.1016\/j.pneurobio.2018.06.011_bib0325","first-page":"S99","article-title":"Human studies related to protein oxidation: protein carbonyl content as a marker of damage","volume":"33","author":"Chevion","year":"2000","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0330","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0335","first-page":"1","article-title":"Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR)","volume":"6366","author":"Ciccone","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0340","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0345","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.drudis.2016.02.002","article-title":"A look into the future of ALS research","volume":"21","author":"Clerc","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0350","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0355","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0960-8966(01)00278-4","article-title":"A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin","volume":"12","author":"Cole","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0360","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2119\/molmed.2013.00011","article-title":"Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat","volume":"19","author":"Consalvi","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0365","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/wrna.1140","article-title":"Exon and intron definition in pre\u2010mRNA splicing","volume":"4","author":"Conti","year":"2013","journal-title":"Wiley Interdiscip."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0370","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnins.2014.00271","article-title":"ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets","volume":"8","author":"Coque","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0375","first-page":"359","article-title":"Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole","volume":"8","author":"Corcia","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0380","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2990.2010.01106.x","article-title":"Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy","volume":"37","author":"Cozzoli","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0385","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1474-4422(13)70221-7","article-title":"Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial","volume":"12","author":"Cudkowicz","year":"2013","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0390","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(14)70222-4","article-title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Cudkowicz","year":"2014","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0395","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.1093\/nar\/gku783","article-title":"Catalytic activities of Werner protein are affected by adduction with 4-hydroxy-2-nonenal","volume":"42","author":"Czerwi\u0144ska","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0400","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13311-015-0337-y","article-title":"Spinal muscular atrophy therapeutics: where do we stand?","volume":"12","author":"d\u2019Ydewalle","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0405","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.10.003","article-title":"PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer","volume":"147","author":"Das","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0410","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0415","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/17460441.2015.1067197","article-title":"A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies","volume":"10","author":"DeLoach","year":"2015","journal-title":"Expert Opin. Drug"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0420","first-page":"63","article-title":"Microglia in amyotrophic lateral sclerosis","volume":"107","author":"Dewil","year":"2007","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0425","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/RRB.S13463","article-title":"Duchenne muscular dystrophy gene therapy: lost in translation?","volume":"2011","author":"Duan","year":"2011","journal-title":"Res. Rep. Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0430","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4593","article-title":"Targeting protein aggregation for the treatment of degenerative diseases","volume":"14","author":"Eisele","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0435","doi-asserted-by":"crossref","first-page":"e0152439","DOI":"10.1371\/journal.pone.0152439","article-title":"Cervical spinal cord atrophy profile in adult SMN1-linked SMA","volume":"11","author":"El Mendili","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0440","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-141899","article-title":"Metabolic modifications in human biofluids suggest the involvement of sphingolipid, antioxidant, and glutamate metabolism in Alzheimer\u2019s disease pathogenesis","volume":"46","author":"Ellis","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey","volume":"1","author":"Emery","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0450","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","article-title":"Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis","volume":"50","author":"Engelhardt","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0455","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0460","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","article-title":"Dystrophin, its interactions with other proteins, and implications for muscular dystrophy","volume":"1772","author":"Ervasti","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0465","doi-asserted-by":"crossref","first-page":"18168","DOI":"10.3390\/molecules201018168","article-title":"Duchenne muscular dystrophy: from diagnosis to therapy","volume":"20","author":"Falzarano","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0470","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1039\/C4CP04549A","article-title":"A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model","volume":"17","author":"Faria","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0475","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI46276","article-title":"Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway","volume":"121","author":"Farooq","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0480","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1073\/pnas.0908540107","article-title":"Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy","volume":"107","author":"Fauconnier","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0485","series-title":"eLS","article-title":"Molecular genetics of dystrophinopathies","author":"Ferlini","year":"2001"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0490","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0495","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/ars.2009.2444","article-title":"Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"11","author":"Foran","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2004.06.002","article-title":"The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo","volume":"17","author":"Fraysse","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0505","first-page":"171","article-title":"Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1","volume":"578","author":"Fumagalli","year":"2008","journal-title":"Eur. J."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0510","first-page":"35","article-title":"Elk-1 a transcription factor with multiple facets in the brain","volume":"5","author":"Galan","year":"2011","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0515","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/acel.12322","article-title":"Relation between TLR4\/NF-\u03baB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability","volume":"14","author":"Gargiulo","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0520","first-page":"6986","article-title":"Genetic inhibition of JNK3 ameliorates spinal muscular atrophy","volume":"24","author":"Genabai","year":"2015","journal-title":"Hum. Mol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0525","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.molmed.2011.08.005","article-title":"Neuroprotective activities of regulatory T cells","volume":"17","author":"Gendelman","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0530","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0535","first-page":"E235","article-title":"Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise","volume":"275","author":"Gibala","year":"1998","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0540","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.PEP.0000127567.98619.62","article-title":"Enhancing participation for children with disabilities: application of the ICF enablement framework to pediatric physical therapist practice","volume":"16","author":"Goldstein","year":"2004","journal-title":"Pediatr. Phys. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0545","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI43844","article-title":"Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle","volume":"121","author":"Goonasekera","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.1256405","article-title":"The role of the Rho GTPases in neuronal development","volume":"19","author":"Govek","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0555","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0960-8966(99)00126-1","article-title":"Pre-clinical screening of drugs using the mdx mouse","volume":"10","author":"Granchelli","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep11443","article-title":"Considerably unfolded transthyretin monomers preceed and exchange with dynamically structured amyloid protofibrils","volume":"5","author":"Groenning","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0565","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"vol. 16","author":"Guiraud","year":"2015"},{"issue":"5350","key":"10.1016\/j.pneurobio.2018.06.011_bib0570","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","article-title":"Rho GTPases and the actin cytoskeleton","volume":"279","author":"Hall","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0575","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/PL00000791","article-title":"Transthyretin: a review from a structural perspective","volume":"58","author":"Hamilton","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0580","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0585","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00726-006-0291-4","article-title":"The effect of taurine depletion on the contractile properties and fatigue in fast-twitch skeletal muscle of the mouse","volume":"31","author":"Hamilton","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0590","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1203\/00006450-199802000-00011","article-title":"Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy","volume":"43","author":"Hankard","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0595","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/humu.20831","article-title":"Microarray-based mutation detection in the dystrophin gene","volume":"29","author":"Hegde","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0600","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0960-8966(92)90004-P","article-title":"The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies","volume":"2","author":"Helliwell","year":"1992","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.06.011_bib0605","doi-asserted-by":"crossref","first-page":"e31202","DOI":"10.1371\/journal.pone.0031202","article-title":"Analysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophy","volume":"7","author":"Hensel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0610","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cellsig.2013.11.027","article-title":"Bilateral crosstalk of rho-and extracellular-signal-regulated-kinase (ERK) pathways is confined to an unidirectional mode in spinal muscular atrophy (SMA)","volume":"26","author":"Hensel","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0615","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnins.2015.00198","article-title":"Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders","volume":"9","author":"Hensel","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0620","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1242\/jcs.113.12.2299","article-title":"Evidence for a myogenic stem cell that is exhausted in dystrophic muscle","volume":"113","author":"Heslop","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0625","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and toxic neuroinflammation in amyotrophic lateral sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0630","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tibs.2014.02.006","article-title":"PTEN function: the long and the short of it","volume":"39","author":"Hopkins","year":"2014","journal-title":"Trends Biochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0635","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4155\/fmc.14.63","article-title":"Advances in therapeutic development for spinal muscular atrophy","volume":"6","author":"Howell","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0640","first-page":"66","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0645","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","article-title":"Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon","volume":"5","author":"Hua","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0650","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/cpt.379","article-title":"Evolving paradigms in clinical pharmacology and therapeutics for the treatment of Duchenne muscular dystrophy","volume":"100","author":"Huard","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0655","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1080\/15476286.2014.996494","article-title":"Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins","volume":"11","author":"Huo","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0660","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1021\/bi049621l","article-title":"Transthyretin aggregation under partially denaturing conditions is a downhill polymerization","volume":"43","author":"Hurshman","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0665","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/jcp.2010.078204","article-title":"Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle","volume":"63","author":"Hussein","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0670","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/path.2411","article-title":"Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis","volume":"216","author":"Ihse","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0675","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"Ihse","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0680","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0143-4160(95)90062-4","article-title":"Abnormal calcium homeostasis in Duchenne muscular-dystrophy myotubes contracting in-vitro","volume":"18","author":"Imbert","year":"1995","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0685","first-page":"197","article-title":"Impaired muscle differentiation in explant cultures of Duchenne muscular-dystrophy","volume":"50","author":"Jasmin","year":"1984","journal-title":"Lab. Investig."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0690","first-page":"1","article-title":"Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis","volume":"4","author":"Jiang","year":"2015","journal-title":"Translational"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0695","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0700","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.yexcr.2011.01.018","article-title":"Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis","volume":"317","author":"Kallestad","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0705","first-page":"1338","article-title":"Glucocorticoid therapy in Duchenne muscular dystrophy","volume":"36","author":"Kang","year":"1996","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0710","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.freeradbiomed.2012.09.010","article-title":"A novel small molecule, N-(4-(2-pyridyl)(1, 3-thiazol-2-yl))-2-(2, 4, 6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by","volume":"53","author":"Kanno","year":"2012","journal-title":"Free Radic. Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0715","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","article-title":"Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus","volume":"270","author":"Kato-Motozaki","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0720","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mad.2010.05.003","article-title":"Mitochondrial dysfunction and intracellular calcium dysregulation in ALS","volume":"131","author":"Kawamata","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0725","first-page":"E585","article-title":"Developmental decline in components of signal transduction pathways regulating protein synthesis in pig muscle","volume":"282","author":"Kimball","year":"2002","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0730","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","article-title":"Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy","volume":"15","author":"Kleopa","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0735","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/01926230290166724","article-title":"Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification","volume":"30","author":"Kohen","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0740","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/0883073807305666","article-title":"Molecular functions of the SMN complex","volume":"22","author":"Kolb","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0745","first-page":"537","article-title":"Neuroinflammation in motor neuron disease","volume":"77","author":"Komine","year":"2015","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0750","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2370","article-title":"Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas","volume":"216","author":"Komohara","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0755","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1073\/pnas.0405972101","article-title":"Heregulin ameliorates the dystrophic phenotype in mdx mice","volume":"101","author":"Krag","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0760","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1471-4159.1999.0720529.x","article-title":"Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis","volume":"72","author":"Kruman","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0765","first-page":"340","article-title":"Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning","volume":"12","author":"Kumar","year":"2016","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0770","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1006868130002","article-title":"Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse","volume":"183","author":"Kuznetsov","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0775","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1023\/A:1007668801570","article-title":"Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain","volume":"25","author":"Kvamme","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0780","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/cvr\/cvs425","article-title":"Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy","volume":"97","author":"Kyrychenko","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0785","first-page":"501","article-title":"Abnormal glycine metabolism in motor neurone disease: studies on plasma and cerebrospinal fluid","volume":"86","author":"Lane","year":"1993","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0790","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and regulation of alternative pre-mRNA splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0795","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/jpm3030144","article-title":"Antisense therapy in neurology","volume":"3","author":"Lee","year":"2013","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0800","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/jpm3030144","article-title":"Antisense therapy in neurology","volume":"3","author":"Lee","year":"2013","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0805","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1523\/JNEUROSCI.4288-04.2005","article-title":"Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0810","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0815","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.24214","article-title":"Sildenafil does not improve cardiomyopathy in Duchenne\/Becker muscular dystrophy","volume":"76","author":"Leung","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0820","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases\u2014what is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0825","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2008.08.008","article-title":"Canonical and non-canonical JAK\u2013STAT signaling","volume":"18","author":"Li","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0830","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1242\/jcs.064808","article-title":"Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin","volume":"123","author":"Li","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0835","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.10.016","article-title":"Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression","volume":"60","author":"Li","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0840","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1038\/cddis.2013.519","article-title":"RhoA\/ROCK\/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0845","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1203\/00006450-198111000-00004","article-title":"Abnormal growth kinetics and 5\u2019-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy","volume":"15","author":"Liechti-Gallati","year":"1981","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0850","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3762\/bjoc.9.82","article-title":"Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)","volume":"9","author":"Limpert","year":"2013","journal-title":"Beilstein J."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0855","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1096\/fasebj.13.15.2318","article-title":"The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids","volume":"13","author":"Liu","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0860","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","article-title":"An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN","volume":"9","author":"Lorson","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0865","first-page":"1177","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"8","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0870","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/339055a0","article-title":"An autosomal transcript in skeletal-muscle with homology to dystrophin","volume":"339","author":"Love","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0875","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/mt.2011.261","article-title":"NF-\u03baB negatively impacts the myogenic potential of muscle-derived stem cells","volume":"20","author":"Lu","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0880","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/1570159X14666160120152423","article-title":"Current therapy of drugs in amyotrophic lateral sclerosis","volume":"14","author":"Lu","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0885","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/35044547","article-title":"RHO GTPASES in neuronal morphogenesis","volume":"1","author":"Luo","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0890","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cbi.2014.10.016","article-title":"Free radicals, reactive oxygen species, oxidative stress and its classification","volume":"224","author":"Lushchak","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0895","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/S0100-879X2002000600009","article-title":"Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells","volume":"35","author":"Luz","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0900","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anpede.2014.06.005","article-title":"Infantile spinal atrophy: our experience in the last 25 years","volume":"82","author":"Madrid Rodr\u00edguez","year":"2015","journal-title":"An. Pediatr\u00eda (English Ed.)"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0905","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/intimm\/dxu099","article-title":"Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective","volume":"27","author":"Malaspina","year":"2015","journal-title":"Int. Immunol."},{"issue":"No. 1","key":"10.1016\/j.pneurobio.2018.06.011_bib0910","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003725.pub3","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0915","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neulet.2005.03.023","article-title":"Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate","volume":"382","author":"Marques","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0920","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/B978-0-12-385883-2.00005-9","article-title":"Biology of mitochondria in neurodegenerative diseases","volume":"107","author":"Martin","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0925","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004327","article-title":"Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy","volume":"4","author":"Martin","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001593","article-title":"A lack of premature termination Codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays","volume":"11","author":"McElroy","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1492(199802)11:1<1::AID-NBM493>3.0.CO;2-D","article-title":"Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair","volume":"11","author":"McIntosh","year":"1998","journal-title":"NMR Biomed."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0940","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Brief report: dystrophin immunity in Duchenne\u2019s muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0945","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0950","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/ja200841e","article-title":"Rational solution growth of r -FeOOH nanowires driven by screw dislocations and their conversion to r -Fe 2 O 3 nanowires","volume":"133","author":"Meng","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0955","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0950-351X(96)80696-3","article-title":"Post-prandial protein metabolism","volume":"10","author":"Millward","year":"1996","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0960","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/2347-8659.135567","article-title":"The M1\/M2 immune polarization concept in microglia: a fair transfer?","volume":"1","author":"Mittelbronn","year":"2014","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0965","doi-asserted-by":"crossref","first-page":"617597","DOI":"10.1155\/2011\/617597","article-title":"Glutamine supplementation in sick children: is it beneficial?","volume":"2011","author":"Mok","year":"2011","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0970","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajcn\/83.4.823","article-title":"Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy","volume":"83","author":"Mok","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0975","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1203\/PDR.0b013e318163a259","article-title":"L-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice","volume":"63","author":"Mok","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0980","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum. Mol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0985","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/13506129.2015.1007497","article-title":"Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B","volume":"22","author":"Moreira","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0990","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1177\/0883073810371004","article-title":"Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management","volume":"25","author":"Moxley","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib0995","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/emmm.201202096","article-title":"Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice","volume":"5","author":"Mozzetta","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1000","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature09823","article-title":"Local, persistent activation of Rho GTPases during plasticity of single dendritic spines","volume":"472","author":"Murakoshi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1005","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N -acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1010","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/WNL.0000000000000498","article-title":"PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy","volume":"82","author":"Nelson","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1015","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2174\/092986712800269326","article-title":"TTR fibril formation inhibitors: is there a SAR?","volume":"19","author":"Nencetti","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1083\/jcb.115.6.1695","article-title":"Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferat","volume":"115","author":"Nguyen","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1025","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1093\/hmg\/ddr425","article-title":"The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin","volume":"20","author":"N\u00f6lle","year":"2011","journal-title":"Hum. Mol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.embor.7400221","article-title":"Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment - third in molecular medicine review series","volume":"5","author":"Nowak","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-1-4684-7971-3_48","article-title":"Inciting excitotoxic cytocide among central neurons","volume":"203","author":"Olney","year":"1986","journal-title":"Excit. Amin. Acids Epilepsy"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2009.06.053","article-title":"Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts","volume":"386","author":"Onopiuk","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jcph.599","article-title":"A personal perspective of orphan drug development for rare diseases: a golden opportunity or an unsustainable future?","volume":"56","author":"Oo","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1050","first-page":"266","article-title":"Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era","volume":"11","author":"Paez-Colasante","year":"2015","journal-title":"Nat. Rev."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/17482968.2011.584627","article-title":"Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically","volume":"12","author":"Paizs","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1065","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2174\/092986712800269335","article-title":"Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?","volume":"19","author":"Palaninathan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1070","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1007\/s00018-013-1415-0","article-title":"Therapeutic neuroprotective agents for amyotrophic lateral sclerosis","volume":"70","author":"Pandya","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1073858407305833","article-title":"The dichotomy of NMDA receptor signaling","volume":"13","author":"Papadia","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1080","first-page":"621","article-title":"Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer\u2019s disease","volume":"140","author":"Pappolla","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1085","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","article-title":"Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP","volume":"29","author":"Parman","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0960-8966(01)00273-5","article-title":"Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice","volume":"12","author":"Passaquin","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/14660820310012736","article-title":"Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment","volume":"4","author":"Pattee","year":"2003","journal-title":"Lateral Scler."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy","volume":"15","author":"Pearn","year":"1978","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1110","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/B978-0-444-52902-2.00038-2","article-title":"Transthyretin familial amyloid polyneuropathy","author":"Plant\u00e9-Bordeneuve","year":"2013"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/GIM.0b013e318188d069","article-title":"Carrier screening for spinal muscular atrophy","volume":"10","author":"Prior","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1125","first-page":"1","article-title":"Downregulation of CREB expression in Alzheimer\u2019s brain and in A\u03b2-treated rat hippocampal neurons","volume":"6","author":"Pugazhenthi","year":"2011","journal-title":"Molecular"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.nmd.2010.07.272","article-title":"170th ENMC International workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27-29 November 2009, Naarden, The Netherlands","volume":"20","author":"Quinlivan","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tins.2003.11.001","article-title":"Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis","volume":"27","author":"Rao","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1140","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1523\/JNEUROSCI.23-07-02627.2003","article-title":"Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons","volume":"23","author":"Rao","year":"2003","journal-title":"J. Neurosci. Off."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jn\/124.6.906","article-title":"Do the differences between the amino-acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states","volume":"124","author":"Reeds","year":"1994","journal-title":"J. Nutr."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1150","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1155","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jcmm.12561","article-title":"Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner","volume":"19","author":"Riahi","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1160","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","article-title":"Rare disease terminology and definitions\u2013a systematic global review: report of the ISPOR rare disease special interest group","volume":"18","author":"Richter","year":"2016","journal-title":"Value Heal."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nchembio.939","article-title":"Synthetic oligonucleotides recruit ILF2\/3 to RNA transcripts to modulate splicing","volume":"8","author":"Rigo","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1170","first-page":"143","volume":"vol. 44","author":"Ruggiero","year":"2011"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1175","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal muscular atrophy: clinical classification and disease heterogeneity","volume":"22","author":"Russman","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1180","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s40265-014-0287-4","article-title":"Ataluren: first global approval","volume":"74","author":"Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115763","article-title":"Defects in mitochondrial ATP synthesis in dystrophin-deficient Mdx skeletal muscles May Be caused by complex I insufficiency","volume":"9","author":"Rybalka","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1190","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.3390\/nu7125498","article-title":"Metabogenic and nutriceutical approaches to address energy dysregulation and skeletal muscle wasting in duchenne muscular dystrophy","volume":"7","author":"Rybalka","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1195","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","article-title":"Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice","volume":"143","author":"Sacco","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1200","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the mechanism of aggregation of human transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd3675","article-title":"Tafamidis","volume":"11","author":"Said","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1210","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2174\/092986712800269236","article-title":"Transthyretin deposition in familial amyloidotic polyneuropathy","volume":"19","author":"Saraiva","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/bib\/bbr021","article-title":"Drug repositioning for orphan diseases","volume":"12","author":"Sardana","year":"2011","journal-title":"Brief. Bioinf."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20210","article-title":"Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis","volume":"51","author":"Sargsyan","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/nen.0b013e31802c396b","article-title":"Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis","volume":"66","author":"Sasaki","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1230","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10409238.2013.786671","article-title":"Rho-associated coiled-coil kinase (ROCK) signaling and disease","volume":"48","author":"Schofield","year":"2013","journal-title":"Crit. Rev. Biochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1235","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/aja.1001980403","article-title":"Expression of the dystrophin-related protein (Utrophin) gene during mouse embryogenesis","volume":"198","author":"Schofield","year":"1993","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1240","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s40265-014-0260-2","article-title":"Tafamidis: a review of its use in familial amyloid polyneuropathy","volume":"74","author":"Scott","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jcpt.12145","article-title":"Recent progress in the understanding and treatment of transthyretin amyloidosis","volume":"39","author":"Sekijima","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1250","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1255","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbadis.2013.08.005","article-title":"Spinal muscular atrophy: an update on therapeutic progress","volume":"1832","author":"Seo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2016.05.016","article-title":"Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis","volume":"97","author":"Seredenina","year":"2016","journal-title":"Free Radic. Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0975-7406.72128","article-title":"Orphan drug: development trends and strategies","volume":"2","author":"Sharma","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1270","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1275","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ana.410380424","article-title":"Oxidative damage to protein in sporadic motor neuron disease spinal cord","volume":"38","author":"Shaw","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem. Int."},{"issue":"Suppl. 2","key":"10.1016\/j.pneurobio.2018.06.011_bib1285","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.3233\/JAD-2010-100366","article-title":"Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis","volume":"20","author":"Shi","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1290","series-title":"eLS","article-title":"Glutamatergic synapses: molecular organisation","author":"Siddoway","year":"2011"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1295","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1083\/jcb.200304021","article-title":"RhoA\/ROCK regulation of neuritogenesis via profilin IIa\u2013mediated control of actin stability","volume":"162","author":"Silva","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1300","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/cb800120t","article-title":"DcpS as a therapeutic target for spinal muscular atrophy","volume":"3","author":"Singh","year":"2008","journal-title":"ACS Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytesbiology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1315","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2008.10.121","article-title":"Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture","volume":"377","author":"S\u00f6rgjerd","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pneurobio.2003.11.002","article-title":"Neurodegeneration in familial amyloid polyneuropathyFrom pathology to molecular signaling","volume":"71","author":"Sousa","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1325","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/labinvest.3780116","article-title":"Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation","volume":"80","author":"Sousa","year":"2000","journal-title":"Lab. Investig."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1330","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy. Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1335","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","article-title":"Familial amyloid polyneuropathyreceptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways","volume":"21","author":"Sousa","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb4150","article-title":"Exon identity crisisdisease-causing mutations that disrupt the splicing code","volume":"15","author":"Sterne-Weiler","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1345","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/B:NERE.0000010438.40376.c9","article-title":"Role of the liver in regulation of body cysteine and taurine levelsA brief review","volume":"29","author":"Stipanuk","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1350","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-015-0326-6","article-title":"Efficacy and safety of patisiran for familial amyloidotic polyneuropathya phase II multi-dose study","volume":"10","author":"Suhr","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nurx.2006.01.010","article-title":"Therapeutics development for spinal muscular atrophy","volume":"3","author":"Sumner","year":"2006","journal-title":"NeuroRX"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1360","first-page":"41","article-title":"Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"232","author":"Tanaka","year":"2011","journal-title":"Experimental"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1365","first-page":"83","article-title":"Rare diseases and orphan drugs","volume":"47","author":"Taruscio","year":"2011","journal-title":"Ann. Ist. Super. Sanita"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1370","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2010.03.004","article-title":"CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis","volume":"222","author":"Tateishi","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1375","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.biocel.2013.07.009","article-title":"Treatment with the cysteine precursor L-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice","volume":"45","author":"Terrill","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1380","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/ddl482","article-title":"Stat5 constitutive activation rescues defects in spinal muscular atrophy","volume":"16","author":"Ting","year":"2007","journal-title":"Hum. Mol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1385","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1390","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy","volume":"35","author":"Tisdale","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1395","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/aws254","article-title":"Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson\u2019s disease","volume":"135","author":"T\u00f6nges","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1400","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1083\/jcb.115.6.1701","article-title":"Increased calcium influx in dystrophic muscle","volume":"115","author":"Turner","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1405","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1074\/jbc.274.4.2234","article-title":"Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production","volume":"274","author":"Uchida","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1410","first-page":"291","article-title":"Progress and promise: the current status of spinal muscular atrophy therapeutics","volume":"12","author":"Van Meerbeke","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1415","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(99)00236-1","article-title":"Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis","volume":"169","author":"Vielhaber","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1420","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/brain\/123.7.1339","article-title":"Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis","volume":"123","author":"Vielhaber","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2005.02.010","article-title":"L-Arginine improves dystrophic phenotype in mdx mice","volume":"20","author":"Voisin","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1430","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tins.2014.05.006","article-title":"Advances in treating amyotrophic lateral sclerosisinsights from pathophysiological studies","volume":"37","author":"Vucic","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1435","first-page":"138","article-title":"Mechanism and site of inhibition of AMPA receptorspairing a thiadiazole with a 2, 3-benzodiazepine scaffold","volume":"5","author":"Wang","year":"2013","journal-title":"ACS Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1440","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/JOM.0000000000000323","article-title":"A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis","volume":"56","author":"Wang","year":"2014","journal-title":"J. Occup. Env. Med."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1445","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1096\/fj.03-0496fje","article-title":"Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised","volume":"18","author":"Warskulat","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1450","doi-asserted-by":"crossref","first-page":"45285","DOI":"10.1074\/jbc.M205177200","article-title":"A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle","volume":"277","author":"Weir","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1455","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0166-2236(00)01610-6","article-title":"Ca2+\u2013Zn2+ permeable AMPA or kainate receptorspossible key factors in selective neurodegeneration","volume":"23","author":"Weiss","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1460","doi-asserted-by":"crossref","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1465","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00001756-200504250-00001","article-title":"Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis","volume":"16","author":"Weydt","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1470","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1469-8749.2004.tb00466.x","article-title":"Specific cognitive deficits are common in children with Duchenne muscular dystrophy","volume":"46","author":"Wicksell","year":"2004","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1475","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.0022-3042.2001.00731.x","article-title":"Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients","volume":"80","author":"Wiedemann","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1480","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1485","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444996003046","article-title":"Structures of human transthyretin complexed with thyroxine at 2.0\u202fA resolution and 3\u2019,5\u2019-dinitro-N-acetyl-L-thyronine at 2.2\u202fA resolution","volume":"52","author":"Wojtczak","year":"1996","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1490","first-page":"322","article-title":"Amino acid availability controls muscle protein metabolism","volume":"12","author":"Wolfe","year":"1999","journal-title":"DIABETES Nutr. Metab."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1495","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/archdischild-2015-308654","article-title":"Short stature and pubertal delay in Duchenne muscular dystrophy","volume":"101","author":"Wood","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1500","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2004.07.118","article-title":"Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS","volume":"322","author":"Wootz","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1505","first-page":"635","article-title":"Mechanism of inhibition of the GluA1 AMPA receptor channel opening by the 2, 3-benzodiazepine compound GYKI 52466 and a N-methyl-carbamoyl derivative","volume":"4","author":"Wu","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1510","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bpc.2014.02.002","article-title":"Mutation and low pH effect on the stability as well as unfolding kinetics of transthyretin dimer","volume":"189","author":"Xue","year":"2014","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1515","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2174\/0929867321666140601162710","article-title":"Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis","volume":"31","author":"Yacila","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1520","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jphs.2015.09.006","article-title":"Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2\u202fH)-dione","volume":"129","author":"Yokoyama","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1525","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/17482960600881870","article-title":"Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)","volume":"7","author":"Yoshino","year":"2006","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1530","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13506129.2012.665400","article-title":"Genotype \u2013 phenotype correlation in FAP","volume":"19","author":"Zeldenrust","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1535","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","article-title":"Immune-mediated Mechanisms in the pathoprogression of amyotrophic lateral sclerosis","volume":"8","author":"Zhao","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1540","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/ph6010085","article-title":"Nanoparticle-based delivery of RNAi TherapeuticsProgress and challenges","volume":"6","author":"Zhou","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pneurobio.2018.06.011_bib1545","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1134\/S0006297907100094","article-title":"The mitochondrion as janus bifrons","volume":"72","author":"Zorov","year":"2007","journal-title":"Biochemistry (Mosc)"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008217302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008217302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T23:52:00Z","timestamp":1661557920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008217302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":309,"alternative-id":["S0301008217302022"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2018.06.011","relation":{},"ISSN":["0301-0082"],"issn-type":[{"type":"print","value":"0301-0082"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}